Skip to content

AbbVie ABBV Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin70.7%+0.4pp70.2%+0.5pp69.7%-1.2pp70.9%+0.2pp70.7%+0.7pp
Operating margin24.4%-0.2pp24.6%
Net margin5.8%-1.1pp6.9%+2.9pp4%-2.4pp6.5%-0.9pp7.3%-0.3pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.4×0.0×0.4×0.0×0.4×0.0×
Liquidity
Current ratio0.8×+0.1×0.7×-0.1×0.7×0.0×0.7×0.0×0.8×+0.1×
Per Share
Book value per share-$3.75-103%-$1.84-23.7%-$1.49-1,343%-$0.10-113%$0.80-57.3%
Valuation
Market capitalization$384.69B-4.7%$403.83B-1.3%$409.03B+24.8%$327.76B-11.6%$370.64B+18.0%
Price / earnings105.8×+10.3×95.6×-75.7×171.3×+84.2×87.1×-1.3×88.4×+14.9×
Price / sales6.1×-0.5×6.6×-0.3×6.9×+1.2×5.6×-0.8×6.5×+0.9×
Dividend yield3.1%+0.2pp2.9%+0.1pp2.8%-0.6pp3.5%+0.4pp3%-0.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are AbbVie's profit margins?
AbbVie (ABBV) runs a 70.7% gross margin and a 24.4% operating margin, with a 5.8% net margin.
Where do AbbVie's ratios come from?
Every ratio is computed from AbbVie's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.